Zhitong Finance App News, Nuocheng Jianhua (09969.HK) announced that the company has reached a strategic research cooperation and licensing agreement with Eli Lilly, the world's leading pharmaceutical company, to develop new drugs. Under the agreement, the company will use its proprietary drug development platform and extensive research experience to develop and advance compounds targeting up to five targets to meet critical unmet medical needs.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Nuocheng Jianhua (09969.HK) announced that the company has reached a strategic research cooperation and licensing agreement with Eli Lilly, the world's leading pharmaceutical company, to develop new drugs. Under the agreement, the company will use its proprietary drug development platform and extensive research experience to develop and advance compounds targeting up to five targets to meet critical unmet medical needs.